DOACs only and warfarin only are more likely to be prescribed to Medicare beneficiaries seeing clinicians in rural areas compared with urban areas.

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) anticoagulant, today highlighted a key opinion leader presen ...

Uttarakhand government endorses medicinal leech therapy as a non-invasive treatment for post-surgical recovery and skin rejuvenation, amidst growing interest and some controversy.

Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the "Company" or "Cadrenal"), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to provide safer and ...

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

VCM-heparinase was able to reverse heparin effect on viscoelastic parameters during ECMO ... that is focused on improving the safety and availability of blood component therapy. Based in North ...

Left atrial appendage occlusion vs continuation of oral anticoagulation therapy alone is linked to reduced ischemic stroke risk in select patients with nonvalvular AF.

Sandra Lesenfants, senior vice president of Abbott’s Structural Heart business, shares an update on MitraClip, TriClip, and ...

Pfizer reported earnings that topped expectations Tuesday following an uptick in sales of a Covid-19 therapeutic and gains from other products.

New evidence supports the use of direct oral anticoagulants in the treatment of cerebral venous thrombosis. Abu Dhabi, UAE — New evidence supports the use of direct oral anticoagulants in the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Much of the research in optimizing anticoagulant therapy for acute VTE has been carried out in patients without malignancies. Given the aggressive natural history of VTE in cancer patients ...